Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | PTGFR | P43088 | 4/20 | 0.74 |
| ▸ | TBXA2R | P21731 | 6/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.73 |
| ▸ | LMNA | P02545 | 4/20 | 0.73 |
| ▸ | PTGER4 | P35408 | 4/20 | 0.73 |
| ▸ | PTGER1 | P34995 | 3/20 | 0.73 |
| ▸ | PTGER3 | P43115 | 3/20 | 0.73 |
| ▸ | SLCO2A1 | Q92959 | 2/20 | 0.73 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.73 |
| ▸ | HPGD | P15428 | 3/20 | 0.64 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.64 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.60 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.60 |
| ▸ | PTGER2 | P43116 | 3/20 | 0.58 |
| ▸ | PTGIR | P43119 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Thromboxane B2 SCHEMBL15263306 | 1.00 | MEN1 (1.00) | MEN1KMT2APTGFRTBXA2RALDH1A1 | |
| Thromboxane B2 SCHEMBL21820779 | 1.00 | MEN1 (1.00) | MEN1KMT2APTGFRTBXA2RALDH1A1 | |
| Thromboxane B2 SCHEMBL13179230 | 1.00 | MEN1 (1.00) | MEN1KMT2APTGFRTBXA2RALDH1A1 | |
| Thromboxane B2 SCHEMBL22972728 | 1.00 | MEN1 (1.00) | MEN1KMT2APTGFRTBXA2RALDH1A1 | |
| SCHEMBL31254102 | 0.92 | MEN1 (0.84) | MEN1KMT2APTGFRTBXA2RALDH1A1 | |
| SCHEMBL29559217 | 0.90 | MEN1 (0.81) | MEN1KMT2APTGFRTBXA2RALDH1A1 | |
| SCHEMBL3344355 | 0.90 | MEN1 (0.81) | MEN1KMT2APTGFRTBXA2RALDH1A1 | |
| SCHEMBL13179231 | 0.90 | MEN1 (0.81) | MEN1KMT2APTGFRTBXA2RALDH1A1 | |
| SCHEMBL38663703 | 0.90 | MEN1 (0.81) | MEN1KMT2APTGFRTBXA2RALDH1A1 | |
| Thromboxane B2 SCHEMBL9545161 | 0.89 | MEN1 (0.79) | MEN1KMT2APTGFRTBXA2RALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3819 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713459-A2 | ANTI-VISTA ANTIBODY RNA OR NUCLEIC ACID CONJUGATES (ARCS OR ANCS), COMPOSITIONS CONTAINING, AND THERAPEUTIC USE THEREOF | LIFORDI IMMUNOTHERAPEUTICS, INC. (US) | 2026-03-25 | — | — | EP | claimed |
| US-20260038636-A1 | METHODS OF TREATING CANCER | FENG BIOSCIENCES, INC. (US) | 2026-02-05 | — | — | US | claimed |
| EP-4678656-A1 | METHODS FOR PRODUCING ATRIOVENTRICULAR CANAL (AVC)-LIKE CARDIOMYOCYTES | Stichting Amsterdam UMC (NL) | 2026-01-14 | — | — | EP | claimed |
| US-20250388862-A1 | SYSTEMS FOR CELL PROGRAMMING AND METHODS THEREOF | SYNTAX BIO INC (US) | 2025-12-25 | — | — | US | claimed |
| EP-4658765-A2 | SYSTEMS FOR CELL PROGRAMMING TOWARDS CHONDROGENIC LINEAGE AND METHODS THEREOF | Syntax Bio, Inc. (US) | 2025-12-10 | — | — | EP | claimed |
| EP-4658760-A2 | SYSTEMS FOR CELL PROGRAMMING TOWARDS PANCREATIC LINEAGE AND METHODS THEREOF | Syntax Bio, Inc. (US) | 2025-12-10 | — | — | EP | claimed |
| US-20250340848-A1 | METHODS FOR CHEMICAL REPROGRAMMING AND PLURIPOTENT STEM CELLS | PEKING UNIVERSITY (CN) | 2025-11-06 | — | — | US | claimed |
| WO-2025184468-A9 | MEASUREMENT OF URINE THROMBOXANE METABOLITES TO PREDICT SURVIVAL | UNIVERSITY OF MASSACHUSETTS (US) | 2025-10-16 | — | — | WO | claimed |
| US-20250320458-A1 | CARDIOMYOCYTE SUBTYPES AND METHODS OF MAKING AND USING | UNIV HEALTH NETWORK (CA) | 2025-10-16 | — | — | US | claimed |
| EP-4622648-A1 | SELECTION OF PATIENTS FOR THE TREATMENT OF FADS1-MEDIATED DISEASES OR DISORDERS USING FADS-1 INHIBITORS | Amgen Inc. (US) | 2025-10-01 | — | — | EP | claimed |
| US-5427913-A | Methods for determining platelet function | ALBERTA CANCER BOARD (CA) | 1995-06-27 | — | — | US | claimed |
| WO-1994012664-A1 | METHODS FOR DETERMINING PLATELET FUNCTION | ALBERTA CANCER BOARD (CA) | 1994-06-09 | — | — | WO | claimed |
| EP-0166583-B1 | COMPOSITIONS FOR ENZYME IMMUNOASSAY OF PROSTAGLANDINS | ONO PHARMACEUTICAL CO., LTD. (JP) | 1991-09-18 | — | — | EP | claimed |
| EP-0361817-A2 | Nucleophilic polysubstituted aryl acridinium esters, conjugates, production and uses thereof | Ciba Corning Diagnostics Corp. (US) | 1990-04-04 | — | — | EP | claimed |
| EP-0310322-A2 | Use of thromboxane B2 to constrict the pupil and lower intraocular pressure | ALLERGAN, INC (US) | 1989-04-05 | — | — | EP | claimed |
| EP-0139552-B1 | COMPOUND LABELLED WITH ACETYLCHOLINE STERASE FROM ELECTROPHORUS ELECTRICUS, METHOD FOR ITS PREPARATION AND ITS USE AS A MARKER IN ENZYME IMMUNO ASSAYS | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1989-02-08 | — | — | EP | claimed |
| EP-0223844-A1 | COMPOUNDS AND METHODS USEFUL FOR THE SYNTHESIS OF THROMBOXANE A 2? | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1987-06-03 | — | — | EP | claimed |
| WO-1986007058-A1 | COMPOUNDS AND METHODS USEFUL FOR THE SYNTHESIS OF THROMBOXANE A2 | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF (US) | 1986-12-04 | — | — | WO | claimed |
| EP-0166583-A2 | Compositions for enzyme immunoassay of prostaglandins | ONO PHARMACEUTICAL CO., LTD. (JP) | 1986-01-02 | — | — | EP | claimed |
| EP-0139552-A1 | Compound labelled with acetylcholine sterase from Electrophorus electricus, method for its preparation and its use as a marker in enzyme immuno assays | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1985-05-02 | — | — | EP | claimed |